Nath Bio-Genes (India) Limited
Símbolo: NATHBIOGEN.NS
NSE
195
INRPrecio de mercado actual
9.0886
Ratio PER
2.0302
Ratio PEG
3.71B
Capitalización MRK
- 0.02%
Rendimiento DIV
Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2089.2 | 41.7 | 292.1 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 1709.3 | 0.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1033.6 | 2456.6 | 2683.8 | ||||||||||||
balance-sheet.row.inventory | 0 | 2078.5 | 2203.4 | 2263 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 7 | 0 | 0 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 5208.3 | 4701.7 | 5238.9 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2339.6 | 2328.5 | 2333 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 50.5 | 50.5 | 50.5 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 218.1 | 136.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 225.4 | 0 | 0 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2719.7 | 2717.4 | 2656.2 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.account-payables | 0 | 277.4 | 550.9 | 452.3 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1048.1 | 922.9 | 959.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 2.8 | 8.9 | 25.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 6.6 | 6.5 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 830.4 | 63.6 | 0 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 31.7 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-liab | 0 | 2196.2 | 1999.4 | 1762.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 190 | 190 | 190 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 4056.6 | 3744.7 | 4456.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 150.1 | 149.9 | 151.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1335 | 1335 | 1335 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5731.7 | 5419.7 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.minority-interest | 0 | -0.2 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 5731.5 | 5419.6 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 50.5 | 50.6 | 50.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1052.1 | 929.6 | 965.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | 672.2 | 887.9 | 673.6 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 361.6 | -633.9 | 567.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 30.1 | 30.8 | 28.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -98.1 | -180.7 | -651.3 | |||||||||||
cash-flows.row.account-receivables | 0 | -118.8 | 210.2 | -20.6 | |||||||||||
cash-flows.row.inventory | 0 | 125 | 59.6 | -219.9 | |||||||||||
cash-flows.row.account-payables | 0 | -150.5 | 199.9 | -229.7 | |||||||||||
cash-flows.row.other-working-capital | 0 | 46.2 | -650.4 | -181.1 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 90 | 954.2 | 66.7 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.5 | 0.7 | 1.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.2 | -0.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -0.5 | -0.7 | -1.5 | |||||||||||
cash-flows.row.other-investing-activites | 0 | -3.4 | 11.7 | 13.7 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.8 | -198.7 | -102.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -122.5 | -78.2 | -252.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | -38 | -38 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 143.9 | -106.1 | 416.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -16.7 | -222.3 | 164 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.1 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 338.1 | -250.5 | 72.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 380 | 41.7 | 292.2 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 41.8 | 292.2 | 219.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 383.7 | 170.5 | 11.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 358.2 | -39.7 | -104.9 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3326.2 | 3012.9 | 2783.6 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1650.8 | 1345.9 | 1239.7 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 1675.4 | 1667 | 1543.9 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 1209.4 | 1208.2 | 1197.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2860.2 | 2554.1 | 2437 | |||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 10.9 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 32.6 | 30.1 | 30.8 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 466 | 457.3 | 345.7 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 381.2 | 363.2 | -633.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 19.5 | 11.5 | 39.5 | |||||||||||||
income-statement-row.row.net-income | 0 | 361.7 | 350.1 | -673.4 |
Preguntas frecuentes
Cuánto es Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) activos totales?
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) los activos totales son 7927970000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.528.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 3.442.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.121.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.147.
¿Qué es Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 361697000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 1052123000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 1209402000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 0.000.